Daratumumab during Myeloma Induction Therapy Is Associated with Impaired Stem Cell Mobilization and Prolonged Post-Transplant Hematologic Recovery von Mehl, Julian, Akhoundova, Dilara, Bacher, Ulrike, Jeker, Barbara, Rhyner Agocs, Gaëlle, Ruefer, Axel, Soltermann, Susanne, Soekler, Martin, Winkler, Annette, Daskalakis, Michael, Pabst, Thomas

Volltext

LAG-3 Expression Predicts Outcome in Stage II Colon Cancer von Rhyner Agocs, Gaëlle, Assarzadegan, Naziheh, Kirsch, Richard, Dawson, Heather, Galván, José A., Lugli, Alessandro, Zlobec, Inti, Berger, Martin D.

Volltext

Alternate-day dosing of pomalidomide in relapsed/ refractory multiple myeloma: a multicenter, single-arm phase 2 trial von Zander, Thilo, Pabst, Thomas, Schär, Sämi, Aebi, Stefan, Mey, Ulrich, Novak, Urban, Lerch, Erika, Rhyner Agocs, Gaëlle, Goede, Jeroen, Maniecka, Zuzanna, Hayoz, Stefanie, Rüfer, Axel, Renner, Christoph, Driessen, Christoph

Volltext

Malignant hypercalcemia von Garin, Dorian, Tornare, Inès, Rhyner Agocs, Gaëlle, Vaucher, Julien, Grandmaison, Gaël

Volltext

Hypercalcémie maligne von Garin, Dorian, Tornare, Inès, Rhyner Agocs, Gaëlle, Vaucher, Julien, Grandmaison, Gaël

Volltext

Immunotherapy: also in elderly patients ? von Rhyner Agocs, Gaëlle, Dougoud-Chauvin, Vérène, Betticher, Daniel

Volltext

Immunothérapie: aussi chez le patient âgé ? von Rhyner Agocs, Gaëlle, Dougoud-Chauvin, Vérène, Betticher, Daniel

Volltext

Immunotherapy: also in elderly patients ? von Rhyner Agocs, Gaëlle, Dougoud-Chauvin, Vérène, Betticher, Daniel

Volltext